Universal Biosensors (UBI) is a global biosensor company and world leader in Point of Care electrochemical sensing. UBI has 20 years of experience developing, manufacturing, and delivering accurate and cost-effective analytical results from a portable handheld analyser using a fingerstick of blood.
Our history includes inventing, developing and:
1.partnering (with Johnson&Johnson “LifeScan”) one of the biggest blood glucose testing products (OneTouch Verio) which has sold more than 10 billion tests globally;
2.commercialising two generations of Point of Care coagulation PT/INR products (Xprecia) which monitor a patients PT/INR levels within seconds, from a fingerstick sample (sold across 36 countries). US FDA 510(k) and CLIA Waiver approval received for Xprecia Prime in March 2024;
3.commercialising a portable handheld analyzer and 6 assays (Sentia) for the monitoring of six key compounds throughout the wine (Oenology) production process;
4.commercialising a veterinary blood glucose monitoring product (Petrackr) for managing cats and dogs with diabetes.
UBI is developing a range of portable Point of Care biomarker monitoring and detection products in oncology, fertility, environmental and water sensing.